Michael Knauer
Prospective cost-effectiveness analysis of genomic profiling in breast cancer
Retèl V, Joore M, Drukker C, Bueno-de-Mesquita J, Knauer M, van Tinteren H, Linn S, van Harten W. Prospective cost-effectiveness analysis of genomic profiling in breast cancer. Eur J Cancer 2013; 49:3773-9.
27.08.2013Prospective cost-effectiveness analysis of genomic profiling in breast cancer
27.08.2013Eur J Cancer 2013; 49:3773-9
Retèl V P, Joore M A, Drukker C A, Bueno-de-Mesquita J M, Knauer Michael, van Tinteren H, Linn S C, van Harten W H
A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study
Drukker C, van de Vijver M, Rutgers E, Sonke G, van 't Veer L, Knauer M, Roumen R, Wesseling J, van Tinteren H, van Harten W, Retèl V, Bueno-de-Mesquita J, Linn S. A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study. Int J Cancer 2013; 133:929-36.
04.03.2013A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study
04.03.2013Int J Cancer 2013; 133:929-36
Drukker C A, van de Vijver M J, Rutgers E J T, Sonke G S, van 't Veer L J, Knauer Michael, Roumen R M H, Wesseling J, van Tinteren H, van Harten W H, Retèl V P, Bueno-de-Mesquita J M, Linn S C
Imaging of bone metastases in prostate cancer: an update
Langsteger W, Haim S, Knauer M, Waldenberger P, Emmanuel K, Loidl W, Wolf I, Beheshti M. Imaging of bone metastases in prostate cancer: an update. Q J Nucl Med Mol Imaging 2012; 56:447-58.
01.10.2012Imaging of bone metastases in prostate cancer: an update
01.10.2012Q J Nucl Med Mol Imaging 2012; 56:447-58
Langsteger W, Haim S, Knauer Michael, Waldenberger P, Emmanuel K, Loidl W, Wolf I, Beheshti M
Results of the First Austrian Multidisciplinary Expert Panel on Controversies in Local Treatment of Breast Cancer
Knauer M, Gnant M, Fitzal F. Results of the First Austrian Multidisciplinary Expert Panel on Controversies in Local Treatment of Breast Cancer. Breast Care (Basel) 2012; 7:61-66.
20.02.2012Results of the First Austrian Multidisciplinary Expert Panel on Controversies in Local Treatment of Breast Cancer
20.02.2012Breast Care (Basel) 2012; 7:61-66
Knauer Michael, Gnant Michael, Fitzal Florian
Brain metastases free survival differs between breast cancer subtypes
Berghoff A, Preusser M, Steger G, Zielinski C, Gnant M, Mader R, Dieckmann K, Fitzal F, Eiter H, Knauer M, Rottenfusser A, Rudas M, Pluschnig U, Dubsky P, De Vries C, Bago-Horvath Z, Bartsch R. Brain metastases free survival differs between breast cancer subtypes. Br J Cancer 2012; 106:440-6.
10.01.2012Brain metastases free survival differs between breast cancer subtypes
10.01.2012Br J Cancer 2012; 106:440-6
Berghoff A, Preusser M, Steger G G, Zielinski C C, Gnant M, Mader R M, Dieckmann K, Fitzal F, Eiter H, Knauer Michael, Rottenfusser A, Rudas M, Pluschnig U, Dubsky P, De Vries C, Bago-Horvath Z, Bartsch R
Impact of mammographic screening on the detection of good and poor prognosis breast cancers
Esserman L, van Leeuwen F, Linn S, Moore D, Glas A, Mook S, Retèl V, Knauer M, Rutgers E, Shieh Y, van 't Veer L. Impact of mammographic screening on the detection of good and poor prognosis breast cancers. Breast Cancer Res Treat 2011; 130:725-34.
04.09.2011Impact of mammographic screening on the detection of good and poor prognosis breast cancers
04.09.2011Breast Cancer Res Treat 2011; 130:725-34
Esserman Laura J, van Leeuwen Flora E, Linn Sabine, Moore Dan H, Glas Annuska M, Mook Stella, Retèl Valesca P, Knauer Michael, Rutgers Emiel J T, Shieh Yiwey, van 't Veer Laura J
Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature
Knauer M, Cardoso F, Wesseling J, Bedard P, Linn S, Rutgers E, van 't Veer L. Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature. Br J Cancer 2010; 103:1788-93.
16.11.2010Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature
16.11.2010Br J Cancer 2010; 103:1788-93
Knauer Michael, Cardoso F, Wesseling J, Bedard P L, Linn S C, Rutgers E J T, van 't Veer L J
Cost-effectiveness of the 70-gene signature versus St. Gallen guidelines and Adjuvant Online for early breast cancer
Retèl V, Joore M, Knauer M, Linn S, Hauptmann M, Harten W. Cost-effectiveness of the 70-gene signature versus St. Gallen guidelines and Adjuvant Online for early breast cancer. Eur J Cancer 2010; 46:1382-91.
30.03.2010Cost-effectiveness of the 70-gene signature versus St. Gallen guidelines and Adjuvant Online for early breast cancer
30.03.2010Eur J Cancer 2010; 46:1382-91
Retèl Valesca P, Joore Manuela A, Knauer Michael, Linn Sabine C, Hauptmann Michael, Harten Wim H van
The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer
Knauer M, Linn S, Bueno-de-Mesquita J, Koornstra R, van de Vijver M, Hauptmann M, Bender R, Rutgers E, Mook S, van 't Veer L. The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer. Breast Cancer Res Treat 2010; 120:655-61.
05.03.2010The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer
05.03.2010Breast Cancer Res Treat 2010; 120:655-61
Knauer Michael, Linn Sabine C, Bueno-de-Mesquita Jolien M, Koornstra Rutger H T, van de Vijver Marc J, Hauptmann Michael, Bender Richard A, Rutgers Emiel J T, Mook Stella, van 't Veer Laura J
Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature
Mook S, Knauer M, Bueno-de-Mesquita J, Retèl V, Wesseling J, Linn S, Van't Veer L, Rutgers E. Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature. Ann Surg Oncol 2010; 17:1406-13.
22.01.2010Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature
22.01.2010Ann Surg Oncol 2010; 17:1406-13
Mook Stella, Knauer Michael, Bueno-de-Mesquita Jolien M, Retèl Valesca P, Wesseling Jelle, Linn Sabine C, Van't Veer Laura J, Rutgers Emiel J
Different types of K-Ras mutations are conversely associated with overall survival in patients with colorectal cancer
Winder T, de Vries A, Wenzl E, Drexel H, Knauer M, Hartmann B, Dirschmid K, Rhomberg S, Mündlein A, Lang A. Different types of K-Ras mutations are conversely associated with overall survival in patients with colorectal cancer. Oncol Rep 2009; 21:1283-7.
01.05.2009Different types of K-Ras mutations are conversely associated with overall survival in patients with colorectal cancer
01.05.2009Oncol Rep 2009; 21:1283-7
Winder Thomas, de Vries Alexander, Wenzl Etienne, Drexel Heinz, Knauer Michael, Hartmann Bernd L, Dirschmid Klaus, Rhomberg Simone, Mündlein Axel, Lang Alois
Gene expression profiling in breast cancer – design of a pooled database to address open questions
Knauer M. Gene expression profiling in breast cancer – design of a pooled database to address open questions. Eur Surg 2009; 41:221-227.
01.01.2009Gene expression profiling in breast cancer – design of a pooled database to address open questions
01.01.2009Eur Surg 2009; 41:221-227
Knauer Michael
Adjuvant extension of chemotherapy after neoadjuvant therapy may not improve outcome in early-stage breast cancer
Knauer M, Wenzl E, Offner F, Säly C, Jasarevic Z, Alton R, Winder T, Lang A, Köberle-Wührer R, Schneider Y, Haid A, deVries A. Adjuvant extension of chemotherapy after neoadjuvant therapy may not improve outcome in early-stage breast cancer. Eur J Surg Oncol 2008; 35:798-804.
14.11.2008Adjuvant extension of chemotherapy after neoadjuvant therapy may not improve outcome in early-stage breast cancer
14.11.2008Eur J Surg Oncol 2008; 35:798-804
Knauer Michael, Wenzl E, Offner F A, Säly C, Jasarevic Z, Alton R, Winder T, Lang A, Köberle-Wührer R, Schneider Y, Haid A, deVries A
Complications after oesophagectomy with possible contribution of neoadjuvant therapy including an EGFR-antibody to a fatal outcome
Knauer M, Haid A, Ammann K, Lang A, Offner F, Türtscher M, Cerkl P, Wenzl E. Complications after oesophagectomy with possible contribution of neoadjuvant therapy including an EGFR-antibody to a fatal outcome. World J Surg Oncol 2007; 5:114.
11.10.2007Complications after oesophagectomy with possible contribution of neoadjuvant therapy including an EGFR-antibody to a fatal outcome
11.10.2007World J Surg Oncol 2007; 5:114
Knauer Michael, Haid Anton, Ammann Karlheinz, Lang Alois, Offner Felix, Türtscher Martina, Cerkl Peter, Wenzl Etienne
Standardization of pathologic complete response rates in breast cancer treatment
Knauer M, Devries A, Wenzl E, Haid A. Standardization of pathologic complete response rates in breast cancer treatment. Breast Cancer Res Treat 2007; 110:395-6.
13.09.2007Standardization of pathologic complete response rates in breast cancer treatment
13.09.2007Breast Cancer Res Treat 2007; 110:395-6
Knauer Michael, Devries Alexander, Wenzl Etienne, Haid Anton
Intra-operative sonography: a valuable aid during breast-conserving surgery for occult breast cancer
Haid A, Wenzl E, Haid B, Toeppker M, Schuster A, Köberle-Wührer R, Jasarevic Z, Dunzinger S, Knauer M, Offner F. Intra-operative sonography: a valuable aid during breast-conserving surgery for occult breast cancer. Ann Surg Oncol 2007; 14:3090-101.
26.06.2007Intra-operative sonography: a valuable aid during breast-conserving surgery for occult breast cancer
26.06.2007Ann Surg Oncol 2007; 14:3090-101
Haid Anton, Wenzl Etienne, Haid Bernhard, Toeppker Michael, Schuster Antonius, Köberle-Wührer Roswitha, Jasarevic Zerina, Dunzinger Stephanie, Knauer Michael, Offner Felix
Multicentric breast cancer: a new indication for sentinel node biopsy--a multi-institutional validation study
Knauer M, Konstantiniuk P, Haid A, Wenzl E, Riegler-Keil M, Pöstlberger S, Reitsamer R, Schrenk P. Multicentric breast cancer: a new indication for sentinel node biopsy--a multi-institutional validation study. J Clin Oncol 2006; 24:3374-80.
20.07.2006Multicentric breast cancer: a new indication for sentinel node biopsy--a multi-institutional validation study
20.07.2006J Clin Oncol 2006; 24:3374-80
Knauer Michael, Konstantiniuk Peter, Haid Anton, Wenzl Etienne, Riegler-Keil Michaela, Pöstlberger Sabine, Reitsamer Roland, Schrenk Peter
Medium-term follow-up data after sentinel node biopsy alone for breast cancer
Haid A, Knauer M, Köberle-Wührer R, Ammann K, Koller L, Eiter H, Lang A, Wenzl E. Medium-term follow-up data after sentinel node biopsy alone for breast cancer. Eur J Surg Oncol 2006; 32:1180-5.
05.06.2006Medium-term follow-up data after sentinel node biopsy alone for breast cancer
05.06.2006Eur J Surg Oncol 2006; 32:1180-5
Haid A, Knauer Michael, Köberle-Wührer R, Ammann K, Koller L, Eiter H, Lang A, Wenzl E
[Mesenteric inflammatory veno-occlusive disease (MIVOD)--a rare cause of intestinal ischemia]
Knauer M, Haid A, Gruber-Mösenbacher U, Wenzl E. [Mesenteric inflammatory veno-occlusive disease (MIVOD)--a rare cause of intestinal ischemia]. Wien Klin Wochenschr 2005; 117:610-4.
01.09.2005[Mesenteric inflammatory veno-occlusive disease (MIVOD)--a rare cause of intestinal ischemia]
01.09.2005Wien Klin Wochenschr 2005; 117:610-4
Knauer Michael, Haid Anton, Gruber-Mösenbacher Ulrike, Wenzl Etienne
[Sentinel node biopsy in breast cancer: techniques and indications]
Haid A, Knauer M, Köberle-Wührer R, Wenzl E. [Sentinel node biopsy in breast cancer: techniques and indications]. Wien Klin Wochenschr 2005; 117:121-8.
01.02.2005[Sentinel node biopsy in breast cancer: techniques and indications]
01.02.2005Wien Klin Wochenschr 2005; 117:121-8
Haid Anton, Knauer Michael, Köberle-Wührer Roswitha, Wenzl Etienne